| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 07/09/2008 | EP1940807A1 Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases |
| 07/09/2008 | EP1940805A1 Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase |
| 07/09/2008 | EP1940802A2 Imidazole compounds for the treatment of neurological disorders |
| 07/09/2008 | EP1940800A1 Novel bicyclic sulfonamides for use as glucocorticoid receptor modulators in the treatment of inflammatory diseases |
| 07/09/2008 | EP1940797A2 8-substituted benzoazepines as toll-like receptor modulators |
| 07/09/2008 | EP1940789A1 Methods and compounds for preparing cc-1065 analogs |
| 07/09/2008 | EP1768978B1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 07/09/2008 | EP1560823B1 4-substituted 1-aminocyclohexane derivatives for utilization as orl1-receptor and mu-opiate receptor ligands |
| 07/09/2008 | CN101218237A Oxime derivative and preparations thereof |
| 07/09/2008 | CN101218235A Bicyclic derivatives as modulators of ion channels |
| 07/09/2008 | CN101218230A Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes |
| 07/09/2008 | CN101218229A Pyrazolyl-amino-substituted pyrimidines and their use in the treatment of cancer |
| 07/09/2008 | CN101218209A Benzimidazole derivatives for treatment of inflammatory diseases |
| 07/09/2008 | CN101218206A Histamine H3 receptor antagonists |
| 07/09/2008 | CN101217958A Inhibitors of AKT activity |
| 07/09/2008 | CN101217957A 2,3 substituted pyrazine sulfonamides as inhibitors of CRTH2 |
| 07/09/2008 | CN100401194C Organic photoreceptor for electronic photographing, image device and method, and charge migration composition |
| 07/09/2008 | CN100400536C Process for preparing candesartan cilexetil C-form crystal |
| 07/09/2008 | CN100400518C Phthalazinone derivatives |
| 07/09/2008 | CN100400040C Tripeptidyl peptidase inhibitors |
| 07/08/2008 | WO2008083353A1 Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/08/2008 | US7396935 p38 kinase inhibitors; inflammatory bowel disease, rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease, and congestive heart failure |
| 07/08/2008 | US7396838 antitumor, anticarcinogenic agents; cytotoxic activity and angiogensis inhibitors; leukemia, colorectal cancer; orally |
| 07/08/2008 | US7396832 Inhibitors of Akt activity |
| 07/08/2008 | US7396831 Vanilloid receptor ligands and their use in treatments |
| 07/08/2008 | CA2710043A1 Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/08/2008 | CA2432131C Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2008 | CA2092868C Process for producing 4-substituted azetidinone derivatives |
| 07/03/2008 | WO2008080056A2 Pyridazinones and furan-containing compounds |
| 07/03/2008 | WO2008079945A2 Rock inhibitors and uses thereof |
| 07/03/2008 | WO2008079933A2 Heteroaryl-heteroaryl compounds as cdk inhibitors for the treatment of cancer, inflammation and viral infections |
| 07/03/2008 | WO2008079918A1 Indol-4-yl-pyrimidinyl-2-yl-amine derivatives and use thereof as cyclin dependant kinase inhibitors |
| 07/03/2008 | WO2008079907A1 Compositions and methods for inhibition of the jak pathway |
| 07/03/2008 | WO2008079159A2 Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| 07/03/2008 | WO2008079073A1 Indazolyl sulphonamide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| 07/03/2008 | WO2008079028A1 Azetidine analogues of nucleosidase and phosphorylase inhibitors |
| 07/03/2008 | WO2008077483A1 Pyrimidinyl pyrazoles as insecticides and parasiticide active agents |
| 07/03/2008 | WO2008043533A3 Acyl aminoimidazoles and acyl aminothiazoles |
| 07/03/2008 | WO2008024980A3 Pyrrole, thiophene, furan, imidazole, oxazole, and thiazole derivatives |
| 07/03/2008 | WO2008019030A3 Modified azole compounds as antiinfective agents |
| 07/03/2008 | WO2008002676A9 Biaryl compositions and methods for modulating a kinase cascade |
| 07/03/2008 | WO2007137417A8 Heterocyclic compounds as calcium channel blockers |
| 07/03/2008 | US20080161562 2-(6-Chloro-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile |
| 07/03/2008 | US20080161558 1-[2-Cyclopentylmethyl-3-(formyl-hydroxy-amino)-propionyl]-pyrrolidine-2-carboxylic acid (5-fluoro-1-oxy-pyridin-2-yl)-amide; inhibitors of peptidyl deformylase (PDF), antimicrobials and antibiotics |
| 07/03/2008 | US20080161556 2-oxo-azepans substituted in the 1- and 3-positions with amides and/or phenyl groups; modulating cell proliferation and/or apoptosis, cancers, proliferative diseases |
| 07/03/2008 | US20080161374 Pyrazole compounds and uses related thereto |
| 07/03/2008 | US20080161373 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 07/03/2008 | US20080161331 e.g. 1-{3-[4-(4,4-dimethyl-4,5-dihydro-1,3-oxazol-2-yl)phenoxy]propyl}piperidine; histamine H3 receptor antagonist; anxiolytic agent, antidepressant, cognition activator; neurodegenerative diseases, eating disorder, attention deficit disorder, Alzheimer's, Parkinson's diseases, schizophrenia |
| 07/03/2008 | US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome |
| 07/03/2008 | US20080161323 Piperazine Derivatives of Alkyl Oxindoles |
| 07/03/2008 | US20080161322 e.g. 1-[2-tert-Butyl-6-(trifluoromethyl)pyrimidin-4-yl]-4-[3-(2-oxo-3,4-dihydroquinolin-1(2H)-yl)propyl]piperazin-4-ium chloride3,4-Dihydroquinolin-2(1H)-one; dopamine D3 receptor antagonists or agonists; antidepressant, schizophrenia, Parkinson's disease |
| 07/03/2008 | US20080161287 Bicyclic compound, production and use thereof |
| 07/03/2008 | US20080161280 Inhibitors of poly(adp-ribose)polymerase |
| 07/03/2008 | US20080161278 2-Azetidinyl-4-(1H-Pyrazol-3-Ylamino) Pyrimidines as Inhibitors of Insulin-Like Growth Factor-1 Receptor Activity |
| 07/03/2008 | US20080160244 Dye and recording media utilizing the same |
| 07/03/2008 | US20080160017 Cross-Linked Antibodies |
| 07/03/2008 | US20080157025 Multiring compound where the benzo ring of benzotriazole UV-absorbers is part of a phthalic acid anhydride or imide system; a large shift of the absorption maximum of approximately 20-30 nm is observed, extending up to 420 nm; light stabilizers for recording material, automotive finishes |
| 07/03/2008 | CA2674525A1 Azetidine analogues of nucleosidase and phosphorylase inhibitors |
| 07/03/2008 | CA2673299A1 Pyridazinones compounds for the treatment of proliferative diseases |
| 07/03/2008 | CA2673003A1 Quinazolines for pdk1 inhibition |
| 07/03/2008 | CA2672989A1 Pyrimidinyl pyrazoles as insecticides and parasiticide active agents |
| 07/03/2008 | CA2672639A1 Indol-4-yl-pyrimidinyl-2-yl-amine derivatives and use thereof as cyclin dependant kinase inhibitors |
| 07/03/2008 | CA2672518A1 Organic compounds and their uses |
| 07/02/2008 | WO2007087518A2 2-substituted benzimidazoles as selective androgen receptor modulators (sarms) |
| 07/02/2008 | EP1939203A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta isoform |
| 07/02/2008 | EP1939189A1 Derivative having ppar agonistic activity |
| 07/02/2008 | EP1939185A1 New types of hetaryl-phenylendiamin-pyrimidines as protein kinase inhibitors for the treatment of cancer |
| 07/02/2008 | EP1938838A1 Histamine h3 agonist for use as therapeutic agent for lipid/glucose metabolic disorder |
| 07/02/2008 | EP1937672A1 N-[(4,5-diphenylpyrimidin-2-yl)methyl]amine derivatives, the preparation thereof and their therapeutic use |
| 07/02/2008 | EP1937668A1 Octahydropentalene-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 07/02/2008 | EP1937667A2 Benzimidazoles useful as inhibitors of protein kinases |
| 07/02/2008 | EP1937664A1 Hydrazide compound and pesticidal use of the same |
| 07/02/2008 | EP1937652A1 Pyrimidine amide compounds as pgds inhibitors |
| 07/02/2008 | EP1937650A1 Heterocyclic compounds |
| 07/02/2008 | EP1937649A1 Imidazole derivatives for the treatment of anxiety and related diseases |
| 07/02/2008 | EP1937638A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors |
| 07/02/2008 | EP1937259A1 Hexahydro-cycloheptapyrazole cannabinoid modulators |
| 07/02/2008 | EP1730117A4 Thiourea compositions and uses thereof |
| 07/02/2008 | EP1646625B1 Pyrrole-2, 5-dithione derivatives as liver x receptor modulators |
| 07/02/2008 | EP1501808B1 Tachykinin receptor antagonists |
| 07/02/2008 | CN101213194A Indazoles useful in treating cardiovascular diseases |
| 07/02/2008 | CN101213192A Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors |
| 07/02/2008 | CN101213191A Antifungal triazole derivatives |
| 07/02/2008 | CN101213190A Compounds and compositions as TPO mimetics |
| 07/02/2008 | CN101213188A Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for beta-secretase modulation |
| 07/02/2008 | CN101213183A Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for beta-secretase modulation |
| 07/02/2008 | CN101213174A Oxindole compounds and their uses as therapeutic agents |
| 07/02/2008 | CN101212969A Azinone and diazinone V3 inhibitors for depression and stress disorders |
| 07/02/2008 | CN101210073A Composition containing bismaleimide oligomer and preparing method thereof |
| 07/02/2008 | CN100398535C Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5 |
| 07/02/2008 | CN100398521C 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase MMP12 |
| 07/02/2008 | CN100398107C Use of IkappaB-kinase inhibitors in preparing medicament for pain therapy |
| 07/02/2008 | CN100398103C Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 07/02/2008 | CA2640046A1 2-substituted benzimidazoles as selective androgen receptor modulators (sarms) |
| 07/01/2008 | US7393870 3-(heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 07/01/2008 | US7393866 Anticholesterol agents; antilipemic agents; cardiovascular disorders; antiischemic agents; anticancer agents |
| 07/01/2008 | US7393852 analgesics; antiinflammatory agents; antiarthritic agents;Alzheimer's disease; cirrhosis; antiallergens; antihistamines ; anticancer agents; vision defects |
| 07/01/2008 | US7393850 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(5-Chloro-1H-indol-3-yl)-piperazine-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 07/01/2008 | US7393844 Tetrahydropyranyl cyclopentyl heterocyclic amide modulators of chemokine receptor activity |
| 07/01/2008 | US7393842 Pyrazole analogs acting on cannabinoid receptors |